Results 11 to 20 of about 17,380 (208)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report

open access: yesSurgical Case Reports, 2022
Background Thrombotic microangiopathy is a syndrome characterized by microangiopathic hemolytic anemia and platelet aggregation, which is caused by endothelial injury, microcirculation thrombosis, and fibrin deposition.
Naohiro Ijiri   +4 more
doaj   +1 more source

Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity

open access: yesFrontiers in Medicine, 2021
Thrombotic microangiopathy is a rare but serious complication that affects kidney transplant recipients. It appears in 0.8–14% of transplanted patients and negatively affects graft and patient survival.
Ana Ávila, Eva Gavela, Asunción Sancho
doaj   +1 more source

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS

open access: yesАкушерство, гинекология и репродукция, 2016
Thrombotic microangiopathy is one of the most serious thrombotic complications characterized by microvascular thrombosis in various organs and accompanied by thrombocytopenia and hemolytic anemia.
S. V. Akinshina   +3 more
doaj   +1 more source

Case Report: A Rare Case of Thrombotic Microangiopathy Induced by Remethylation Disorders

open access: yesFrontiers in Medicine, 2022
In this research, we described a very rare case of thrombotic microangiopathy induced by remethylation disorders. A 16-year-old boy presented to the emergency department with 5 months of weakness and fatigue.
Lu Pang   +6 more
doaj   +1 more source

The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

open access: yesBMC Infectious Diseases, 2021
Background The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated.
Magnus Holter Bjørkto   +8 more
doaj   +1 more source

Syndromes of Thrombotic Microangiopathy [PDF]

open access: yesNew England Journal of Medicine, 2014
This review article covers the diverse pathophysiological pathways that can lead to microangiopathic hemolytic anemia and a procoagulant state with or without damage to the kidneys and other organs.
Koemhoff, Martin   +2 more
openaire   +7 more sources

Potential Role of Platelet-Activating C-Type Lectin-Like Proteins in Viper Envenomation Induced Thrombotic Microangiopathy Symptom

open access: yesToxins, 2020
Envenomation by viperid snakes may lead to severe bleeding, consumption coagulopathy, and thrombotic microangiopathy symptoms. The exact etiology or toxins responsible for thrombotic microangiopathy symptoms after snake envenomation remain obscure. Snake
Chengbo Long   +9 more
doaj   +1 more source

Pathogenesis of Thrombotic Microangiopathies [PDF]

open access: yesAnnual Review of Pathology: Mechanisms of Disease, 2007
Profound thrombocytopenia and microangiopathic hemolytic anemia characterize thrombotic microangiopathy, which includes two major disorders: thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP has at least three types: congenital or familial, idiopathic, and nonidiopathic.
X Long, Zheng, J Evan, Sadler
openaire   +2 more sources

Perindopril/amlodipine-induced thrombotic microangiopathy

open access: yesTurkish Journal of Emergency Medicine, 2021
This is the first report on a case of perindopril/amlodipine-induced thrombotic microangiopathy (TMA) syndrome. A 48-year-old female was admitted complaining of nettle rash all over the body, bloody urine, and weakness shortly after starting ...
Vlatka Perisa   +3 more
doaj   +1 more source

The PLASMIC Score May Be Useful in the Early Diagnosis of Complement-Mediated Thrombotic Microangiopathy via Early Exclusion of Thrombotic Thrombocytopenic Purpura

open access: yesCase Reports in Medicine, 2019
Complement-mediated thrombotic microangiopathy is a rare form of thrombotic microangiopathy but has high rates of mortality and morbidity. Effective treatment exists with eculizumab for this condition, but administration of treatment is often delayed ...
Edwin Lu, Willie Moore
doaj   +1 more source

Home - About - Disclaimer - Privacy